世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 生物製剤とバイオシミラーの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年Global Biologics and Biosimilars Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031 2024年、生物製剤とバイオシミラーの世界市場規模は441320万米ドルと推定され、2031年には約784010万米ドルに達すると予測され、予測期間2025-2031年の年平均成長率は8.7%である。 生物製剤は、生きた細胞で作... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー2024年、生物製剤とバイオシミラーの世界市場規模は441320万米ドルと推定され、2031年には約784010万米ドルに達すると予測され、予測期間2025-2031年の年平均成長率は8.7%である。生物製剤は、生きた細胞で作られる非常に特異的で効果の高い医薬品であり、歴史的には動物であることが多かった。生物製剤には、ホルモン、サイトカイン、成長因子、ワクチン、遺伝子・細胞治療、融合タンパク質、インスリン、インターフェロン、モノクローナル抗体（mAb）製剤などが含まれる。 バイオシミラー（生物学的製剤の後続品または後発品とも呼ばれる）とは、他社が製造した先発品とほぼ同一の生物学的製剤のことである。バイオシミラー医薬品は、「イノベーター」である先発品から正式に承認されたものであり、先発品の特許が切れた時点で製造が可能となる。イノベーター製品への言及は、承認に不可欠な要素である。 世界の主要な生物製剤およびバイオシミラーメーカーには、ジョンソン・エンド・ジョンソン、ファイザー、ロシュ、アムジェン、アッヴィなどがある。上位5社で市場シェアの約50％を占め、最大手はファイザーでシェア20％を超えている。製品カテゴリー別では、モノクローナル抗体の市場シェアが43％と最も大きく、次いでワクチンのシェアが30％となっている。用途別では、病院がトップで市場シェアの約85%を占めている。 レポートの範囲 本レポートは、生物製剤およびバイオシミラーの世界市場を定量的・定性的分析の両面から包括的に紹介し、読者がビジネス／成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、生物製剤およびバイオシミラーに関する十分な情報に基づいたビジネス上の意思決定を行うのに役立つことを目的としています。 生物製剤とバイオシミラーの市場規模、推計、予測は、2024年を基準年とし、2020年から2031年までの期間の履歴データと予測データを加えた収益（百万ドル）で提供されます。本レポートでは、世界の生物製剤とバイオシミラー市場を包括的に区分しています。製品タイプ別、用途別、プレイヤー別の地域別市場規模も掲載しています。 市場のより詳細な理解のために、競合状況、主要競合企業のプロフィール、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。 本レポートは、この市場における生物製剤およびバイオシミラーの企業、新規参入企業、業界チェーン関連企業にとって、市場全体および企業別、製品タイプ別、用途別、地域別の異なるセグメントにわたるサブセグメントの収益に関する情報を提供する一助となることでしょう。 市場セグメンテーション 企業別 ロシュ アムジェン アッヴィ サノフィ ジョンソン・エンド・ジョンソン ファイザー ノボ ノルディスク イーライリリー ノバルティス メルク バイオジェン セルトリオン ソビ 3SBIO 長春ハイテク カンホン製薬 イノベントバイオロジクス ガン＆リー 通化東宝 ユナイテッド・ラボラトリー タイプ別セグメント モノクローナル抗体 インターフェロン インスリン ワクチン その他 用途別セグメント 病院 小売薬局 その他 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 インド 東南アジア オーストラリア その他のアジア太平洋地域 欧州 ドイツ フランス 英国 イタリア ロシア 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章：報告書のスコープ、各市場セグメント（製品タイプ、用途など）の市場規模、将来的な発展の可能性などのエグゼクティブサマリーを紹介。 第2章：生物製剤とバイオシミラーの世界および地域レベルでの収益 第3章：生物製剤・バイオシミラー企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。 第4章：主要企業のプロフィールを提供し、製品の説明と仕様、生物製剤とバイオシミラーの収益、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第5章：各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展の可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。 第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の収益。 第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別収益 第9章：アジア太平洋地域：タイプ別、用途別、地域別、セグメント別収益 第10章：ラテンアメリカ：タイプ別、用途別、国別、セグメント別収益。 第11章：中東・アフリカ：タイプ別、用途別、国別、セグメント別収益。 第12章：産業チェーンの分析、販売チャネル、主要原材料、流通業者、顧客。 第13章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。 第14章 調査結果と結論 目次1 Study Coverage1.1 Biologics and Biosimilars Product Introduction 1.2 Market by Type 1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type (2020 VS 2024 VS 2031) 1.2.2 Monoclonal Antibodies 1.2.3 Interferon 1.2.4 Insulin 1.2.5 Vaccines 1.2.6 Others 1.3 Market by Application 1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application (2020 VS 2024 VS 2031) 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Other 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Biologics and Biosimilars Market Size Estimates and Forecasts 2.2 Biologics and Biosimilars Market Size by Region: 2024 Versus 2031 2.2.1 Global Biologics and Biosimilars Revenue by Region: 2020-2025 2.2.2 Global Biologics and Biosimilars Revenue Forecast by Region (2026-2031) 2.2.3 Global Biologics and Biosimilars Revenue Market Share by Region (2020-2031) 3 Market Segments 3.1 Breakdown Data by Type 3.1.1 Global Biologics and Biosimilars Revenue by Type (2020-2031) 3.1.2 Global Biologics and Biosimilars Revenue Market Share by Type (2020-2031) 3.2 Breakdown Data by Application 3.2.1 Global Biologics and Biosimilars Revenue by Application (2020-2031) 3.2.2 Global Biologics and Biosimilars Revenue Market Share by Application (2020-2031) 3.3 by Type and by Application Crossing Analysis 3.3.1 Monoclonal Antibodies of Biologics and Biosimilars Revenue Market Share by Application 3.3.2 Interferon of Biologics and Biosimilars Revenue Market Share by Application 3.3.3 Insulin of Biologics and Biosimilars Revenue Market Share by Application 3.3.4 Vaccines of Biologics and Biosimilars Revenue Market Share by Application 3.3.5 Others of Biologics and Biosimilars Revenue Market Share by Application 4 Global Biologics and Biosimilars by Company 4.1 Global Biologics and Biosimilars Revenue by Company (2020-2025) 4.2 Global Biologics and Biosimilars Revenue Share by Company (2020-2025) 4.3 Competitive Landscape 4.3.1 Key Biologics and Biosimilars Companies around the World: Ranking by Revenue 4.3.2 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI) & (2020-2025) 4.3.3 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.4 Global Biologics and Biosimilars Companies Headquarters & Product Type 4.4.1 Global Biologics and Biosimilars Companies Headquarters 4.4.2 Date of International Companies Enter into Biologics and Biosimilars Market 4.4.3 Global Biologics and Biosimilars Companies Product & Service 4.4.4 Monoclonal Antibodies Revenue Market Share of Biologics and Biosimilars by Company 4.4.5 Interferon Revenue Market Share of Biologics and Biosimilars by Company 4.4.6 Insulin Revenue Market Share of Biologics and Biosimilars by Company 4.4.7 Vaccines Revenue Market Share of Biologics and Biosimilars by Company 4.4.8 Others Revenue Market Share of Biologics and Biosimilars by Company 4.5 Global Biologics and Biosimilars Mergers & Acquisitions, Expansion Plans 5 Company Profiles 5.1 Roche 5.1.1 Roche Corporation Information 5.1.2 Roche Description, Business Overview 5.1.3 Roche Biologics and Biosimilars Products Offered 5.1.4 Roche Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.1.5 Roche Biologics and Biosimilars Revenue by Product in 2024 5.1.6 Roche Biologics and Biosimilars Revenue by Application in 2024 5.1.7 Roche Biologics and Biosimilars Revenue by Geographic Area in 2024 5.1.8 Roche Recent Developments 5.2 Amgen 5.2.1 Amgen Corporation Information 5.2.2 Amgen Description, Business Overview 5.2.3 Amgen Biologics and Biosimilars Products Offered 5.2.4 Amgen Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.2.5 Amgen Biologics and Biosimilars Revenue by Product in 2024 5.2.6 Amgen Biologics and Biosimilars Revenue by Application in 2024 5.2.7 Amgen Biologics and Biosimilars Revenue by Geographic Area in 2024 5.2.8 Amgen Recent Developments 5.3 AbbVie 5.3.1 AbbVie Corporation Information 5.3.2 AbbVie Description, Business Overview 5.3.3 AbbVie Biologics and Biosimilars Products Offered 5.3.4 AbbVie Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.3.5 AbbVie Biologics and Biosimilars Revenue by Product in 2024 5.3.6 AbbVie Biologics and Biosimilars Revenue by Application in 2024 5.3.7 AbbVie Biologics and Biosimilars Revenue by Geographic Area in 2024 5.3.8 AbbVie Recent Developments 5.4 Sanofi 5.4.1 Sanofi Corporation Information 5.4.2 Sanofi Description, Business Overview 5.4.3 Sanofi Biologics and Biosimilars Products Offered 5.4.4 Sanofi Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.4.5 Sanofi Biologics and Biosimilars Revenue by Product in 2024 5.4.6 Sanofi Biologics and Biosimilars Revenue by Application in 2024 5.4.7 Sanofi Biologics and Biosimilars Revenue by Geographic Area in 2024 5.4.8 Sanofi Recent Developments 5.5 Johnson & Johnson 5.5.1 Johnson & Johnson Corporation Information 5.5.2 Johnson & Johnson Description, Business Overview 5.5.3 Johnson & Johnson Biologics and Biosimilars Products Offered 5.5.4 Johnson & Johnson Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.5.5 Johnson & Johnson Biologics and Biosimilars Revenue by Product in 2024 5.5.6 Johnson & Johnson Biologics and Biosimilars Revenue by Application in 2024 5.5.7 Johnson & Johnson Biologics and Biosimilars Revenue by Geographic Area in 2024 5.5.8 Johnson & Johnson Recent Developments 5.6 Pfizer 5.6.1 Pfizer Corporation Information 5.6.2 Pfizer Description, Business Overview 5.6.3 Pfizer Biologics and Biosimilars Products Offered 5.6.4 Pfizer Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.6.5 Pfizer Biologics and Biosimilars Revenue by Product in 2024 5.6.6 Pfizer Biologics and Biosimilars Revenue by Application in 2024 5.6.7 Pfizer Biologics and Biosimilars Revenue by Geographic Area in 2024 5.6.8 Pfizer Recent Developments 5.7 Novo Nordisk 5.7.1 Novo Nordisk Corporation Information 5.7.2 Novo Nordisk Description, Business Overview 5.7.3 Novo Nordisk Biologics and Biosimilars Products Offered 5.7.4 Novo Nordisk Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.7.5 Novo Nordisk Biologics and Biosimilars Revenue by Product in 2024 5.7.6 Novo Nordisk Biologics and Biosimilars Revenue by Application in 2024 5.7.7 Novo Nordisk Biologics and Biosimilars Revenue by Geographic Area in 2024 5.7.8 Novo Nordisk Recent Developments 5.8 Eli Lilly 5.8.1 Eli Lilly Corporation Information 5.8.2 Eli Lilly Description, Business Overview 5.8.3 Eli Lilly Biologics and Biosimilars Products Offered 5.8.4 Eli Lilly Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.8.5 Eli Lilly Biologics and Biosimilars Revenue by Product in 2024 5.8.6 Eli Lilly Biologics and Biosimilars Revenue by Application in 2024 5.8.7 Eli Lilly Biologics and Biosimilars Revenue by Geographic Area in 2024 5.8.8 Eli Lilly Recent Developments 5.9 Novartis 5.9.1 Novartis Corporation Information 5.9.2 Novartis Description, Business Overview 5.9.3 Novartis Biologics and Biosimilars Products Offered 5.9.4 Novartis Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.9.5 Novartis Biologics and Biosimilars Revenue by Product in 2024 5.9.6 Novartis Biologics and Biosimilars Revenue by Application in 2024 5.9.7 Novartis Biologics and Biosimilars Revenue by Geographic Area in 2024 5.9.8 Novartis Recent Developments 5.10 Merck 5.10.1 Merck Corporation Information 5.10.2 Merck Description, Business Overview 5.10.3 Merck Biologics and Biosimilars Products Offered 5.10.4 Merck Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.10.5 Merck Biologics and Biosimilars Revenue by Product in 2024 5.10.6 Merck Biologics and Biosimilars Revenue by Application in 2024 5.10.7 Merck Biologics and Biosimilars Revenue by Geographic Area in 2024 5.10.8 Merck Recent Developments 5.11 Biogen 5.11.1 Biogen Corporation Information 5.11.2 Biogen Description, Business Overview 5.11.3 Biogen Biologics and Biosimilars Products Offered 5.11.4 Biogen Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.11.5 Biogen Biologics and Biosimilars Revenue by Product in 2024 5.11.6 Biogen Biologics and Biosimilars Revenue by Application in 2024 5.11.7 Biogen Biologics and Biosimilars Revenue by Geographic Area in 2024 5.11.8 Biogen Recent Developments 5.12 Celltrion 5.12.1 Celltrion Corporation Information 5.12.2 Celltrion Description, Business Overview 5.12.3 Celltrion Biologics and Biosimilars Products Offered 5.12.4 Celltrion Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.12.5 Celltrion Biologics and Biosimilars Revenue by Product in 2024 5.12.6 Celltrion Biologics and Biosimilars Revenue by Application in 2024 5.12.7 Celltrion Biologics and Biosimilars Revenue by Geographic Area in 2024 5.12.8 Celltrion Recent Developments 5.13 Sobi 5.13.1 Sobi Corporation Information 5.13.2 Sobi Description, Business Overview 5.13.3 Sobi Biologics and Biosimilars Products Offered 5.13.4 Sobi Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.13.5 Sobi Biologics and Biosimilars Revenue by Product in 2024 5.13.6 Sobi Biologics and Biosimilars Revenue by Application in 2024 5.13.7 Sobi Biologics and Biosimilars Revenue by Geographic Area in 2024 5.13.8 Sobi Recent Developments 5.14 3SBIO 5.14.1 3SBIO Corporation Information 5.14.2 3SBIO Description, Business Overview 5.14.3 3SBIO Biologics and Biosimilars Products Offered 5.14.4 3SBIO Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.14.5 3SBIO Biologics and Biosimilars Revenue by Product in 2024 5.14.6 3SBIO Biologics and Biosimilars Revenue by Application in 2024 5.14.7 3SBIO Biologics and Biosimilars Revenue by Geographic Area in 2024 5.14.8 3SBIO Recent Developments 5.15 Changchun High Tech 5.15.1 Changchun High Tech Corporation Information 5.15.2 Changchun High Tech Description, Business Overview 5.15.3 Changchun High Tech Biologics and Biosimilars Products Offered 5.15.4 Changchun High Tech Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.15.5 Changchun High Tech Biologics and Biosimilars Revenue by Product in 2024 5.15.6 Changchun High Tech Biologics and Biosimilars Revenue by Application in 2024 5.15.7 Changchun High Tech Biologics and Biosimilars Revenue by Geographic Area in 2024 5.15.8 Changchun High Tech Recent Developments 5.16 Kanghong Pharma 5.16.1 Kanghong Pharma Corporation Information 5.16.2 Kanghong Pharma Description, Business Overview 5.16.3 Kanghong Pharma Biologics and Biosimilars Products Offered 5.16.4 Kanghong Pharma Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.16.5 Kanghong Pharma Biologics and Biosimilars Revenue by Product in 2024 5.16.6 Kanghong Pharma Biologics and Biosimilars Revenue by Application in 2024 5.16.7 Kanghong Pharma Biologics and Biosimilars Revenue by Geographic Area in 2024 5.16.8 Kanghong Pharma Recent Developments 5.17 Innovent Biologics 5.17.1 Innovent Biologics Corporation Information 5.17.2 Innovent Biologics Description, Business Overview 5.17.3 Innovent Biologics Biologics and Biosimilars Products Offered 5.17.4 Innovent Biologics Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.17.5 Innovent Biologics Biologics and Biosimilars Revenue by Product in 2024 5.17.6 Innovent Biologics Biologics and Biosimilars Revenue by Application in 2024 5.17.7 Innovent Biologics Biologics and Biosimilars Revenue by Geographic Area in 2024 5.17.8 Innovent Biologics Recent Developments 5.18 Gan&Lee 5.18.1 Gan&Lee Corporation Information 5.18.2 Gan&Lee Description, Business Overview 5.18.3 Gan&Lee Biologics and Biosimilars Products Offered 5.18.4 Gan&Lee Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.18.5 Gan&Lee Biologics and Biosimilars Revenue by Product in 2024 5.18.6 Gan&Lee Biologics and Biosimilars Revenue by Application in 2024 5.18.7 Gan&Lee Biologics and Biosimilars Revenue by Geographic Area in 2024 5.18.8 Gan&Lee Recent Developments 5.19 Tonghua Dongbao 5.19.1 Tonghua Dongbao Corporation Information 5.19.2 Tonghua Dongbao Description, Business Overview 5.19.3 Tonghua Dongbao Biologics and Biosimilars Products Offered 5.19.4 Tonghua Dongbao Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.19.5 Tonghua Dongbao Biologics and Biosimilars Revenue by Product in 2024 5.19.6 Tonghua Dongbao Biologics and Biosimilars Revenue by Application in 2024 5.19.7 Tonghua Dongbao Biologics and Biosimilars Revenue by Geographic Area in 2024 5.19.8 Tonghua Dongbao Recent Developments 5.20 United Laboratory 5.20.1 United Laboratory Corporation Information 5.20.2 United Laboratory Description, Business Overview 5.20.3 United Laboratory Biologics and Biosimilars Products Offered 5.20.4 United Laboratory Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.20.5 United Laboratory Biologics and Biosimilars Revenue by Product in 2024 5.20.6 United Laboratory Biologics and Biosimilars Revenue by Application in 2024 5.20.7 United Laboratory Biologics and Biosimilars Revenue by Geographic Area in 2024 5.20.8 United Laboratory Recent Developments 6 North America 6.1 North America Biologics and Biosimilars Market Size YoY Growth 2020-2031 6.2 North America Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 6.3 North America Biologics and Biosimilars Revenue by Type (2020-2025) 6.4 North America Biologics and Biosimilars Revenue by Application (2020-2025) 7 Asia-Pacific 7.1 Asia-Pacific Biologics and Biosimilars Market Size YoY Growth 2020-2031 7.2 Asia-Pacific Biologics and Biosimilars Market Facts & Figures by Region (2020-2031) 7.3 Asia-Pacific Biologics and Biosimilars Revenue by Type (2020-2025) 7.4 Asia-Pacific Biologics and Biosimilars Revenue by Application (2020-2025) 8 Europe 8.1 Europe Biologics and Biosimilars Market Size YoY Growth 2020-2031 8.2 Europe Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 8.3 Europe Biologics and Biosimilars Revenue by Type (2020-2025) 8.4 Europe Biologics and Biosimilars Revenue by Application (2020-2025) 9 Latin America 9.1 Latin America Biologics and Biosimilars Market Size YoY Growth 2020-2031 9.2 Latin America Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 9.3 Latin America Biologics and Biosimilars Revenue by Type (2020-2025) 9.4 Latin America Biologics and Biosimilars Revenue by Application (2020-2025) 10 Middle East and Africa 10.1 Latin America Biologics and Biosimilars Market Size YoY Growth 2020-2031 10.2 Middle East and Africa Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 10.3 Middle East and Africa Biologics and Biosimilars Revenue by Type (2020-2025) 10.4 Middle East and Africa Biologics and Biosimilars Revenue by Application (2020-2025) 11 Supply Chain and Sales Channel analysis 11.1 Biologics and Biosimilars Supply Chain Analysis 11.2 Biologics and Biosimilars Key Raw Materials and Upstream Suppliers 11.3 Biologics and Biosimilars Clients Analysis 11.4 Biologics and Biosimilars Sales Channel and Sales Model Analysis 11.4.1 Biologics and Biosimilars Distribution Channel Analysis: Indirect Sales VS Direct Sales 11.4.2 Biologics and Biosimilars Distribution Channel Analysis: Online Sales VS Offline Sales 11.4.3 Biologics and Biosimilars Distributors 12 Biologics and Biosimilars Market Dynamics 12.1 Biologics and Biosimilars Industry Trends 12.2 Biologics and Biosimilars Market Drivers 12.3 Biologics and Biosimilars Market Challenges 12.4 Biologics and Biosimilars Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
SummaryIn 2024, the global market size of Biologics and Biosimilars was estimated to be worth US$ 441320 million and is forecast to reach approximately US$ 784010 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031. Table of Contents1 Study Coverage1.1 Biologics and Biosimilars Product Introduction 1.2 Market by Type 1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type (2020 VS 2024 VS 2031) 1.2.2 Monoclonal Antibodies 1.2.3 Interferon 1.2.4 Insulin 1.2.5 Vaccines 1.2.6 Others 1.3 Market by Application 1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application (2020 VS 2024 VS 2031) 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Other 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Biologics and Biosimilars Market Size Estimates and Forecasts 2.2 Biologics and Biosimilars Market Size by Region: 2024 Versus 2031 2.2.1 Global Biologics and Biosimilars Revenue by Region: 2020-2025 2.2.2 Global Biologics and Biosimilars Revenue Forecast by Region (2026-2031) 2.2.3 Global Biologics and Biosimilars Revenue Market Share by Region (2020-2031) 3 Market Segments 3.1 Breakdown Data by Type 3.1.1 Global Biologics and Biosimilars Revenue by Type (2020-2031) 3.1.2 Global Biologics and Biosimilars Revenue Market Share by Type (2020-2031) 3.2 Breakdown Data by Application 3.2.1 Global Biologics and Biosimilars Revenue by Application (2020-2031) 3.2.2 Global Biologics and Biosimilars Revenue Market Share by Application (2020-2031) 3.3 by Type and by Application Crossing Analysis 3.3.1 Monoclonal Antibodies of Biologics and Biosimilars Revenue Market Share by Application 3.3.2 Interferon of Biologics and Biosimilars Revenue Market Share by Application 3.3.3 Insulin of Biologics and Biosimilars Revenue Market Share by Application 3.3.4 Vaccines of Biologics and Biosimilars Revenue Market Share by Application 3.3.5 Others of Biologics and Biosimilars Revenue Market Share by Application 4 Global Biologics and Biosimilars by Company 4.1 Global Biologics and Biosimilars Revenue by Company (2020-2025) 4.2 Global Biologics and Biosimilars Revenue Share by Company (2020-2025) 4.3 Competitive Landscape 4.3.1 Key Biologics and Biosimilars Companies around the World: Ranking by Revenue 4.3.2 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI) & (2020-2025) 4.3.3 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.4 Global Biologics and Biosimilars Companies Headquarters & Product Type 4.4.1 Global Biologics and Biosimilars Companies Headquarters 4.4.2 Date of International Companies Enter into Biologics and Biosimilars Market 4.4.3 Global Biologics and Biosimilars Companies Product & Service 4.4.4 Monoclonal Antibodies Revenue Market Share of Biologics and Biosimilars by Company 4.4.5 Interferon Revenue Market Share of Biologics and Biosimilars by Company 4.4.6 Insulin Revenue Market Share of Biologics and Biosimilars by Company 4.4.7 Vaccines Revenue Market Share of Biologics and Biosimilars by Company 4.4.8 Others Revenue Market Share of Biologics and Biosimilars by Company 4.5 Global Biologics and Biosimilars Mergers & Acquisitions, Expansion Plans 5 Company Profiles 5.1 Roche 5.1.1 Roche Corporation Information 5.1.2 Roche Description, Business Overview 5.1.3 Roche Biologics and Biosimilars Products Offered 5.1.4 Roche Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.1.5 Roche Biologics and Biosimilars Revenue by Product in 2024 5.1.6 Roche Biologics and Biosimilars Revenue by Application in 2024 5.1.7 Roche Biologics and Biosimilars Revenue by Geographic Area in 2024 5.1.8 Roche Recent Developments 5.2 Amgen 5.2.1 Amgen Corporation Information 5.2.2 Amgen Description, Business Overview 5.2.3 Amgen Biologics and Biosimilars Products Offered 5.2.4 Amgen Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.2.5 Amgen Biologics and Biosimilars Revenue by Product in 2024 5.2.6 Amgen Biologics and Biosimilars Revenue by Application in 2024 5.2.7 Amgen Biologics and Biosimilars Revenue by Geographic Area in 2024 5.2.8 Amgen Recent Developments 5.3 AbbVie 5.3.1 AbbVie Corporation Information 5.3.2 AbbVie Description, Business Overview 5.3.3 AbbVie Biologics and Biosimilars Products Offered 5.3.4 AbbVie Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.3.5 AbbVie Biologics and Biosimilars Revenue by Product in 2024 5.3.6 AbbVie Biologics and Biosimilars Revenue by Application in 2024 5.3.7 AbbVie Biologics and Biosimilars Revenue by Geographic Area in 2024 5.3.8 AbbVie Recent Developments 5.4 Sanofi 5.4.1 Sanofi Corporation Information 5.4.2 Sanofi Description, Business Overview 5.4.3 Sanofi Biologics and Biosimilars Products Offered 5.4.4 Sanofi Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.4.5 Sanofi Biologics and Biosimilars Revenue by Product in 2024 5.4.6 Sanofi Biologics and Biosimilars Revenue by Application in 2024 5.4.7 Sanofi Biologics and Biosimilars Revenue by Geographic Area in 2024 5.4.8 Sanofi Recent Developments 5.5 Johnson & Johnson 5.5.1 Johnson & Johnson Corporation Information 5.5.2 Johnson & Johnson Description, Business Overview 5.5.3 Johnson & Johnson Biologics and Biosimilars Products Offered 5.5.4 Johnson & Johnson Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.5.5 Johnson & Johnson Biologics and Biosimilars Revenue by Product in 2024 5.5.6 Johnson & Johnson Biologics and Biosimilars Revenue by Application in 2024 5.5.7 Johnson & Johnson Biologics and Biosimilars Revenue by Geographic Area in 2024 5.5.8 Johnson & Johnson Recent Developments 5.6 Pfizer 5.6.1 Pfizer Corporation Information 5.6.2 Pfizer Description, Business Overview 5.6.3 Pfizer Biologics and Biosimilars Products Offered 5.6.4 Pfizer Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.6.5 Pfizer Biologics and Biosimilars Revenue by Product in 2024 5.6.6 Pfizer Biologics and Biosimilars Revenue by Application in 2024 5.6.7 Pfizer Biologics and Biosimilars Revenue by Geographic Area in 2024 5.6.8 Pfizer Recent Developments 5.7 Novo Nordisk 5.7.1 Novo Nordisk Corporation Information 5.7.2 Novo Nordisk Description, Business Overview 5.7.3 Novo Nordisk Biologics and Biosimilars Products Offered 5.7.4 Novo Nordisk Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.7.5 Novo Nordisk Biologics and Biosimilars Revenue by Product in 2024 5.7.6 Novo Nordisk Biologics and Biosimilars Revenue by Application in 2024 5.7.7 Novo Nordisk Biologics and Biosimilars Revenue by Geographic Area in 2024 5.7.8 Novo Nordisk Recent Developments 5.8 Eli Lilly 5.8.1 Eli Lilly Corporation Information 5.8.2 Eli Lilly Description, Business Overview 5.8.3 Eli Lilly Biologics and Biosimilars Products Offered 5.8.4 Eli Lilly Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.8.5 Eli Lilly Biologics and Biosimilars Revenue by Product in 2024 5.8.6 Eli Lilly Biologics and Biosimilars Revenue by Application in 2024 5.8.7 Eli Lilly Biologics and Biosimilars Revenue by Geographic Area in 2024 5.8.8 Eli Lilly Recent Developments 5.9 Novartis 5.9.1 Novartis Corporation Information 5.9.2 Novartis Description, Business Overview 5.9.3 Novartis Biologics and Biosimilars Products Offered 5.9.4 Novartis Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.9.5 Novartis Biologics and Biosimilars Revenue by Product in 2024 5.9.6 Novartis Biologics and Biosimilars Revenue by Application in 2024 5.9.7 Novartis Biologics and Biosimilars Revenue by Geographic Area in 2024 5.9.8 Novartis Recent Developments 5.10 Merck 5.10.1 Merck Corporation Information 5.10.2 Merck Description, Business Overview 5.10.3 Merck Biologics and Biosimilars Products Offered 5.10.4 Merck Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.10.5 Merck Biologics and Biosimilars Revenue by Product in 2024 5.10.6 Merck Biologics and Biosimilars Revenue by Application in 2024 5.10.7 Merck Biologics and Biosimilars Revenue by Geographic Area in 2024 5.10.8 Merck Recent Developments 5.11 Biogen 5.11.1 Biogen Corporation Information 5.11.2 Biogen Description, Business Overview 5.11.3 Biogen Biologics and Biosimilars Products Offered 5.11.4 Biogen Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.11.5 Biogen Biologics and Biosimilars Revenue by Product in 2024 5.11.6 Biogen Biologics and Biosimilars Revenue by Application in 2024 5.11.7 Biogen Biologics and Biosimilars Revenue by Geographic Area in 2024 5.11.8 Biogen Recent Developments 5.12 Celltrion 5.12.1 Celltrion Corporation Information 5.12.2 Celltrion Description, Business Overview 5.12.3 Celltrion Biologics and Biosimilars Products Offered 5.12.4 Celltrion Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.12.5 Celltrion Biologics and Biosimilars Revenue by Product in 2024 5.12.6 Celltrion Biologics and Biosimilars Revenue by Application in 2024 5.12.7 Celltrion Biologics and Biosimilars Revenue by Geographic Area in 2024 5.12.8 Celltrion Recent Developments 5.13 Sobi 5.13.1 Sobi Corporation Information 5.13.2 Sobi Description, Business Overview 5.13.3 Sobi Biologics and Biosimilars Products Offered 5.13.4 Sobi Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.13.5 Sobi Biologics and Biosimilars Revenue by Product in 2024 5.13.6 Sobi Biologics and Biosimilars Revenue by Application in 2024 5.13.7 Sobi Biologics and Biosimilars Revenue by Geographic Area in 2024 5.13.8 Sobi Recent Developments 5.14 3SBIO 5.14.1 3SBIO Corporation Information 5.14.2 3SBIO Description, Business Overview 5.14.3 3SBIO Biologics and Biosimilars Products Offered 5.14.4 3SBIO Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.14.5 3SBIO Biologics and Biosimilars Revenue by Product in 2024 5.14.6 3SBIO Biologics and Biosimilars Revenue by Application in 2024 5.14.7 3SBIO Biologics and Biosimilars Revenue by Geographic Area in 2024 5.14.8 3SBIO Recent Developments 5.15 Changchun High Tech 5.15.1 Changchun High Tech Corporation Information 5.15.2 Changchun High Tech Description, Business Overview 5.15.3 Changchun High Tech Biologics and Biosimilars Products Offered 5.15.4 Changchun High Tech Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.15.5 Changchun High Tech Biologics and Biosimilars Revenue by Product in 2024 5.15.6 Changchun High Tech Biologics and Biosimilars Revenue by Application in 2024 5.15.7 Changchun High Tech Biologics and Biosimilars Revenue by Geographic Area in 2024 5.15.8 Changchun High Tech Recent Developments 5.16 Kanghong Pharma 5.16.1 Kanghong Pharma Corporation Information 5.16.2 Kanghong Pharma Description, Business Overview 5.16.3 Kanghong Pharma Biologics and Biosimilars Products Offered 5.16.4 Kanghong Pharma Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.16.5 Kanghong Pharma Biologics and Biosimilars Revenue by Product in 2024 5.16.6 Kanghong Pharma Biologics and Biosimilars Revenue by Application in 2024 5.16.7 Kanghong Pharma Biologics and Biosimilars Revenue by Geographic Area in 2024 5.16.8 Kanghong Pharma Recent Developments 5.17 Innovent Biologics 5.17.1 Innovent Biologics Corporation Information 5.17.2 Innovent Biologics Description, Business Overview 5.17.3 Innovent Biologics Biologics and Biosimilars Products Offered 5.17.4 Innovent Biologics Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.17.5 Innovent Biologics Biologics and Biosimilars Revenue by Product in 2024 5.17.6 Innovent Biologics Biologics and Biosimilars Revenue by Application in 2024 5.17.7 Innovent Biologics Biologics and Biosimilars Revenue by Geographic Area in 2024 5.17.8 Innovent Biologics Recent Developments 5.18 Gan&Lee 5.18.1 Gan&Lee Corporation Information 5.18.2 Gan&Lee Description, Business Overview 5.18.3 Gan&Lee Biologics and Biosimilars Products Offered 5.18.4 Gan&Lee Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.18.5 Gan&Lee Biologics and Biosimilars Revenue by Product in 2024 5.18.6 Gan&Lee Biologics and Biosimilars Revenue by Application in 2024 5.18.7 Gan&Lee Biologics and Biosimilars Revenue by Geographic Area in 2024 5.18.8 Gan&Lee Recent Developments 5.19 Tonghua Dongbao 5.19.1 Tonghua Dongbao Corporation Information 5.19.2 Tonghua Dongbao Description, Business Overview 5.19.3 Tonghua Dongbao Biologics and Biosimilars Products Offered 5.19.4 Tonghua Dongbao Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.19.5 Tonghua Dongbao Biologics and Biosimilars Revenue by Product in 2024 5.19.6 Tonghua Dongbao Biologics and Biosimilars Revenue by Application in 2024 5.19.7 Tonghua Dongbao Biologics and Biosimilars Revenue by Geographic Area in 2024 5.19.8 Tonghua Dongbao Recent Developments 5.20 United Laboratory 5.20.1 United Laboratory Corporation Information 5.20.2 United Laboratory Description, Business Overview 5.20.3 United Laboratory Biologics and Biosimilars Products Offered 5.20.4 United Laboratory Biologics and Biosimilars Revenue and Gross Margin (2020-2025) 5.20.5 United Laboratory Biologics and Biosimilars Revenue by Product in 2024 5.20.6 United Laboratory Biologics and Biosimilars Revenue by Application in 2024 5.20.7 United Laboratory Biologics and Biosimilars Revenue by Geographic Area in 2024 5.20.8 United Laboratory Recent Developments 6 North America 6.1 North America Biologics and Biosimilars Market Size YoY Growth 2020-2031 6.2 North America Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 6.3 North America Biologics and Biosimilars Revenue by Type (2020-2025) 6.4 North America Biologics and Biosimilars Revenue by Application (2020-2025) 7 Asia-Pacific 7.1 Asia-Pacific Biologics and Biosimilars Market Size YoY Growth 2020-2031 7.2 Asia-Pacific Biologics and Biosimilars Market Facts & Figures by Region (2020-2031) 7.3 Asia-Pacific Biologics and Biosimilars Revenue by Type (2020-2025) 7.4 Asia-Pacific Biologics and Biosimilars Revenue by Application (2020-2025) 8 Europe 8.1 Europe Biologics and Biosimilars Market Size YoY Growth 2020-2031 8.2 Europe Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 8.3 Europe Biologics and Biosimilars Revenue by Type (2020-2025) 8.4 Europe Biologics and Biosimilars Revenue by Application (2020-2025) 9 Latin America 9.1 Latin America Biologics and Biosimilars Market Size YoY Growth 2020-2031 9.2 Latin America Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 9.3 Latin America Biologics and Biosimilars Revenue by Type (2020-2025) 9.4 Latin America Biologics and Biosimilars Revenue by Application (2020-2025) 10 Middle East and Africa 10.1 Latin America Biologics and Biosimilars Market Size YoY Growth 2020-2031 10.2 Middle East and Africa Biologics and Biosimilars Market Facts & Figures by Country (2020-2031) 10.3 Middle East and Africa Biologics and Biosimilars Revenue by Type (2020-2025) 10.4 Middle East and Africa Biologics and Biosimilars Revenue by Application (2020-2025) 11 Supply Chain and Sales Channel analysis 11.1 Biologics and Biosimilars Supply Chain Analysis 11.2 Biologics and Biosimilars Key Raw Materials and Upstream Suppliers 11.3 Biologics and Biosimilars Clients Analysis 11.4 Biologics and Biosimilars Sales Channel and Sales Model Analysis 11.4.1 Biologics and Biosimilars Distribution Channel Analysis: Indirect Sales VS Direct Sales 11.4.2 Biologics and Biosimilars Distribution Channel Analysis: Online Sales VS Offline Sales 11.4.3 Biologics and Biosimilars Distributors 12 Biologics and Biosimilars Market Dynamics 12.1 Biologics and Biosimilars Industry Trends 12.2 Biologics and Biosimilars Market Drivers 12.3 Biologics and Biosimilars Market Challenges 12.4 Biologics and Biosimilars Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（biologics）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
